BLOG

Coronavirus In Minnesota: HealthPartners Begins Clinical Trial For Drug To Treat COVID-19 Pneumonia Patients

HealthPartners is now testing a drug which could treat severe COVID-19 pneumonia patients. The drug – called CM4620-IE – received fast-track approval from the FDA earlier this month, allowing HealthPartners to begin clinical trials.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}